⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMNN News
Imunon, Inc. Common Stock
Form 8-K
sec.gov
IMNN
Form 8-K
sec.gov
IMNN
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
IMNN
IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026
globenewswire.com
IMNN
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
globenewswire.com
IMNN
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development
globenewswire.com
IMNN
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
globenewswire.com
IMNN
Form 8-K
sec.gov
IMNN
BFRG
INM
GLMD
IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification
globenewswire.com
IMNN
IMUNON to Present at the Life Sciences Investor Forum on June 25th
globenewswire.com
IMNN